Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Ryan Savitz
»
Articles
»
XLV
|
Ryan Savitz
23
Followers
1
Following
You are currently following Ryan Savitz
Stop Following
You are no longer following Ryan Savitz
Profile
Articles (14)
Comments (6)
Johnson & Johnson: Is It Too Late?
on Oct 15, 2008
•
JNJ
,
XLV
More on XLV by Ryan Savitz
Instablogs »
StockTalks »
Comments »
Articles by Ticker
ABT
,
AMGN
,
BDX
,
BRL
,
CVD
,
DNA
,
GILD
,
ICLR
,
JNJ
,
KNDL
,
MDT
,
MRK
,
MYL
,
NVS
,
PFE
,
PPDI
,
PRXL
,
RHHBY.PK
,
SNN
,
SYK
,
TEVA
,
XLV
,
ZMH
Latest Comments on Ryan Savitz's Articles
ArtfulDodger
on
Stryker Corp Looks Good for Health Care Rebound
: Name one area of the economy that the government has delved into...
more »
Tim Hiteshew
on
Stryker Corp Looks Good for Health Care Rebound
: I am long SYK as well, but we may not see earnings improve for...
more »
khaz
on
Stryker Corp Looks Good for Health Care Rebound
: Health care reform is a big headwind near term, no question. But...
more »
Mad Hedge Fund Trader
on
Stryker Corp Looks Good for Health Care Rebound
: These stocks are discounting a new future. I met with Dr....
more »
Ryan Vanzo
on
Stryker Corp Looks Good for Health Care Rebound
: I agree, and am long SYK. Good luck with your Nittany Lion Fund,...
more »
donzelion
on
Downturn Has Transformed Drug Company Business Model
: "It seems that for the current time period, it is more cost...
more »
TATyszka
on
Downturn Has Transformed Drug Company Business Model
: To add to the above comment -- this, from a report from Turner...
more »
upndown1313
on
Downturn Has Transformed Drug Company Business Model
: Write facts, but wrong interpretation. Big Pharma spending at CRO...
more »
stevenm1968
on
Teva: What's Next for the 'Generic Giant'?
: There is some noise on the internet about Teva buying Watson and I...
more »
felixd
on
Abbott, Teva: Tough Enough to Withstand Rocky Market
: I think the author here has missed the bigger point about the FDA...
more »
mdpath
on
Abbott, Teva: Tough Enough to Withstand Rocky Market
: Is there any specific news to account for ABT's sudden decline or...
more »
Ryan Savitz
on
Teva: What's Next for the 'Generic Giant'?
: Well if you look at the history of Teva and how they have grown,...
more »
Chris B
on
Teva: What's Next for the 'Generic Giant'?
: So we should buy this company on the basis of how well they've...
more »
bbowen7
on
Teva: What's Next for the 'Generic Giant'?
: Acquisitions are complex, and require financial resources, a...
more »
Michael Eisenberg
on
Teva: What's Next for the 'Generic Giant'?
: This is an incredibly well run company. I know the CFO who just...
more »
Latest Comments on Ryan Savitz's Articles
Latest Comments on Ryan Savitz's Articles